Company-wide revenue
Reported revenue in 2020 ¥112.98B Reported revenue in 2024 ¥122.7B
- growth amount
- +¥9.73B
- growth annualized
- +2.1%
- growth total
- +8.6%
Japanese company profile · 2689
In its FY2024 public filing, OLBA DVx HEALTHCARE,Inc. reports Medical devices, SPD business, Assistive technology. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: オルバヘルスケアホールディングス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
What does this company do?
OLBA DVx HEALTHCARE,Inc.'s largest reported business by revenue in FY2024 was Medical devices.
The business with the highest reported segment profit in FY2024 was Medical devices.
FY2024 · fiscal year ended June 2025 View original filing ↗ The source document may be in Japanese.
Business structure
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Medical devices | ¥115.88B ↗ | 94.4% | ¥1.77B ↗ |
| SPD business | ¥5.72B ↗ | 4.7% | ¥113.91M ↗ |
| Assistive technology | ¥2.78B ↗ | 2.3% | ¥205.18M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2024 · fiscal year ended June 2025. Revenue and profit are shown only where the filing and data support a comparison.
What is growing?
Reported revenue in 2020 ¥112.98B Reported revenue in 2024 ¥122.7B
Reported revenue in 2020 ¥97.81B Reported revenue in 2024 ¥115.88B
Reported revenue in 2020 ¥2.32B Reported revenue in 2024 ¥2.78B
Reported profit margin in 2021 +7.2%
Reported profit margin in 2024 +7.4%
This describes a reported period; it is not a forecast.
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
FY2024 · fiscal year ended June 2025
The source document may be in Japanese.
Filing ID: S100WQ48
View original filing ↗Ask about this company
The source document may be in Japanese.